Ravi Ganapathy
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike protein.
Journal: Scientific reports
Published: March 17, 2025
Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine.
Journal: Vaccine
Published: October 18, 2024
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
Journal: The Lancet. Global health
Published: July 05, 2023
Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.
Journal: The American journal of tropical medicine and hygiene
Published: May 01, 2023
Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine.
Journal: Scientific reports
Published: July 27, 2021
Scalable production and immunogenicity of a cholera conjugate vaccine.
Journal: Vaccine
Published: July 06, 2021
Showing 1-7 of 7
Last Updated: 09/26/2026